For instance, Zheng et al. demonstrated that EVs derived from HUC-MSCs can protect liver injury in mice ischemia/reperfusion injury (IRI) model through downregulating CD154 expression on intrahepatic CD4+T cells because the CD154 highly expressed CD4+T cells would trigger the inflammatory response in liver and deteriorate liver IRI. This evidence concerns the gene CD4 and ischemia.